[go: up one dir, main page]

WO2012021409A3 - Anthraquinone Analogs - Google Patents

Anthraquinone Analogs Download PDF

Info

Publication number
WO2012021409A3
WO2012021409A3 PCT/US2011/046794 US2011046794W WO2012021409A3 WO 2012021409 A3 WO2012021409 A3 WO 2012021409A3 US 2011046794 W US2011046794 W US 2011046794W WO 2012021409 A3 WO2012021409 A3 WO 2012021409A3
Authority
WO
WIPO (PCT)
Prior art keywords
anthraquinone analogs
anthraquinone
analogs
methods
diones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/046794
Other languages
French (fr)
Other versions
WO2012021409A2 (en
Inventor
Cheng Wei Tom Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Utah State University
Original Assignee
Utah State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Utah State University filed Critical Utah State University
Publication of WO2012021409A2 publication Critical patent/WO2012021409A2/en
Publication of WO2012021409A3 publication Critical patent/WO2012021409A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/22—Naphthotriazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anthraquinone analogs, methods for synthesizing anthraquinone analogs, and methods for inhibiting growth of one or more types of cells using anthraquinone analogs. Anthraquinone analogs can be synsthesized according to methods described herein. Optionally, the synthesis methods described herein include choosing an appropriate leaving group for selectively producing 1-alkyl-1H-naphtho[2,3-d]triazole-4,9-diones or 2-alkyl-2H-naphtho[2,3-d]triazole-4,9-diones. Anthraquinone analogs can include various functional groups that affect their ability to inhibit the growth of various cell types. For example, some anthraquinone analogs disclosed herein have antimicrobial activity while seemingly similar compounds demonstrate anticancer activity but lesser antimicrobial activity.
PCT/US2011/046794 2010-08-11 2011-08-05 Anthraquinone Analogs Ceased WO2012021409A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37253010P 2010-08-11 2010-08-11
US61/372,530 2010-08-11

Publications (2)

Publication Number Publication Date
WO2012021409A2 WO2012021409A2 (en) 2012-02-16
WO2012021409A3 true WO2012021409A3 (en) 2012-05-24

Family

ID=45568143

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/046794 Ceased WO2012021409A2 (en) 2010-08-11 2011-08-05 Anthraquinone Analogs

Country Status (1)

Country Link
WO (1) WO2012021409A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103880715B (en) * 2012-12-19 2016-04-06 张家港市国泰华荣化工新材料有限公司 A kind of method of continuous production trifluoromethanesulfonic acid ethyl ester
CN108467370B (en) * 2017-11-29 2021-11-23 四川大学 Triazole naphthoquinone bi-aromatic ring derivative or triazole naphthoquinone bi-aromatic heterocyclic derivative, and preparation method and application thereof
CN109293588B (en) * 2018-11-14 2022-02-01 四川大学 Small molecular compound with IDO1/TDO dual-target, and preparation method and application thereof
CN110218198B (en) * 2019-05-22 2022-06-28 广州中医药大学(广州中医药研究院) Naphthoquinone triazole core skeleton derivative compound and preparation method and application thereof
WO2025039722A1 (en) * 2023-08-22 2025-02-27 东南大学 Naphthoquinone compound, and preparation method therefor, pharmaceutical composition thereof and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033214A2 (en) * 1980-01-23 1981-08-05 Beecham Group Plc Process for preparing therapeutically active triazoles
EP0033215A2 (en) * 1980-01-23 1981-08-05 Beecham Group Plc Process for preparing anti-allergy naphthotriazoles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033214A2 (en) * 1980-01-23 1981-08-05 Beecham Group Plc Process for preparing therapeutically active triazoles
EP0033215A2 (en) * 1980-01-23 1981-08-05 Beecham Group Plc Process for preparing anti-allergy naphthotriazoles

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JIANJUN ZHANG ET AL.: "Divergent Synthesis of Three Classes of Aryl N-Glucosides by Solvent Controle", JOURNAL OF ORGANIC CHEMISTRY, vol. 74, no. 2, 2009, pages 685 - 695 *
JIANJUN ZHANG ET AL.: "Synthesis and antibaceterial activity study of a novel class of cationinc anthraquinone analogs", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 19, no. 11, 2011, pages 498 - 503 *
SATISH G. BODIGE ET AL.: "2-Amino-1,2,3-triazole derivatives", JOURNAL OF CHEMICAL CRYSTALLOGRAPH, vol. 29, no. 12, 1999, pages 1225 - 1234 *

Also Published As

Publication number Publication date
WO2012021409A2 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
WO2011107462A3 (en) Sun protection compositions
WO2012135025A3 (en) Conjugated lipomers and uses thereof
HK1205697A1 (en) Prodrugs of hydroxyl-comprising drugs
MX358682B (en) Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators.
PH12012502352A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
WO2011133876A3 (en) Oligonucleotides comprising acyclic and abasic nucleosides and analogs
EP3699176A3 (en) Antiviral compounds
WO2014059238A8 (en) Modulation of androgen receptor expression
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
HK1215579A1 (en) Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
MX2011008176A (en) 3, 3' -spiroindolinone derivatives as anticancer agents.
WO2012054664A3 (en) Ink compositions
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
WO2008083950A3 (en) Spirocyclic tetronic acid derivatives
WO2011143772A9 (en) Inhibitors of hiv replication
CA2873723A1 (en) Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
WO2012021409A3 (en) Anthraquinone Analogs
WO2010135401A3 (en) Kinase-mediated cytoprotection and enhanced cellular engraftment and persistence
WO2011126245A3 (en) Novel method of preparing vanadosilicate molecular sieve and novel vanadosilicate molecular sieve
WO2013093931A3 (en) Novel prodrugs of phenolic drugs
WO2013181343A3 (en) Potted plant systems and methods of making and using the same
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
MX2010009453A (en) Topotecan ready to use solutions.
HK1205686A1 (en) Novel prodrug containing molecule compostions and their uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816863

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816863

Country of ref document: EP

Kind code of ref document: A2